MedPath

Dalili, Nooshin

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Effects of Pentoxifylline After Cardiac Surgery

Not Applicable
Completed
Conditions
Oxidative Stress
AKI
Inflammation
First Posted Date
2018-07-19
Last Posted Date
2018-07-19
Lead Sponsor
nooshin dalili
Target Recruit Count
100
Registration Number
NCT03591536

The Frequency and Risk Factors of Delayed Graft Function

Completed
Conditions
Delayed Graft Function
Kidney Transplant; Complications
First Posted Date
2018-06-13
Last Posted Date
2018-06-13
Lead Sponsor
nooshin dalili
Target Recruit Count
500
Registration Number
NCT03555513

Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis

Not Applicable
Completed
Conditions
Hemodialysis Complication
Interventions
Dietary Supplement: Lactobacillus rhamnosus
Drug: Placebo - Cap
First Posted Date
2018-05-17
Last Posted Date
2018-05-17
Lead Sponsor
nooshin dalili
Target Recruit Count
42
Registration Number
NCT03527680

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.